| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | James J Yoo | Q87640591 |
| Kang Su Cho | Q63901813 | ||
| P2093 | author name string | In Kap Ko | |
| P2860 | cites work | Metanephric transforming growth factor-alpha is required for renal organogenesis in vitro | Q68098740 |
| Epidermal growth factor accelerates renal repair in mercuric chloride nephrotoxicity | Q68911965 | ||
| Modulation of HGF-induced tubulogenesis and branching by multiple phosphorylation mechanisms | Q70495134 | ||
| HGF-induced tubulogenesis and branching of epithelial cells is modulated by extracellular matrix and TGF-beta | Q72638374 | ||
| Therapeutic use of growth factors in renal failure | Q72775877 | ||
| Expression of bone morphogenetic protein-7 mRNA in normal and ischemic adult rat kidney | Q74591270 | ||
| How does G-CSF act on the kidney during acute tubular injury? | Q80093926 | ||
| Renal ischemia reperfusion inhibits VEGF expression and induces ADAMTS-1, a novel VEGF inhibitor | Q80694420 | ||
| BMP7 is a podocyte survival factor and rescues podocytes from diabetic injury | Q81097445 | ||
| Hematopoietic stem cell mobilization therapy accelerates recovery of renal function independent of stem cell contribution | Q81648757 | ||
| Phenolic antioxidants tert-butyl-bisphenol and vitamin E decrease oxidative stress and enhance vascular function in an animal model of rhabdomyolysis yet do not improve acute renal dysfunction | Q84499670 | ||
| Combined systemic and local delivery of stem cell inducing/recruiting factors for in situ tissue regeneration | Q85030674 | ||
| Erythropoietin and protection of renal function in cardiac surgery (the EPRICS Trial) | Q85319317 | ||
| Drugs to foster kidney regeneration in experimental animals and humans | Q87935220 | ||
| The Role of Galectin-3 in the Kidneys | Q26752754 | ||
| Stem cells as drug delivery methods: application of stem cell secretome for regeneration | Q26862657 | ||
| Regenerative medicine for the kidney: renotropic factors, renal stem/progenitor cells, and stem cell therapy | Q26865171 | ||
| Interleukin-22 in kidney injury and regeneration | Q27687335 | ||
| BMP-7 regulates chemokine, cytokine, and hemodynamic gene expression in proximal tubule cells | Q28215207 | ||
| Bone morphogenetic protein-7 improves renal fibrosis and accelerates the return of renal function | Q28215638 | ||
| TGFβ signalling in context | Q28275410 | ||
| Up-regulation of galectin-3 in acute renal failure of the rat | Q28344724 | ||
| Induction of heparin-binding epidermal growth factor-like growth factor mRNA in rat kidney after acute injury | Q28367933 | ||
| Angiotensin II stimulates Pax-2 in rat kidney proximal tubular cells: impact on proliferation and apoptosis | Q28566861 | ||
| Role of PDGF B-chain and PDGF receptors in rat tubular regeneration after acute injury | Q28581591 | ||
| Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1 | Q29615241 | ||
| Spatial and temporally restricted expression of chemokines and chemokine receptors in the developing human kidney. | Q30827847 | ||
| Bone morphogenetic protein-7 delays podocyte injury due to high glucose | Q33293656 | ||
| Melatonin promoted renal regeneration in folic acid-induced acute kidney injury via inhibiting nucleocytoplasmic translocation of HMGB1 in tubular epithelial cells | Q33623118 | ||
| Role of renal microcirculation in experimental renovascular disease. | Q33988621 | ||
| Hepatocyte growth factor: renotropic role and potential therapeutics for renal diseases | Q34266530 | ||
| The role of the activin-follistatin system in the developmental and regeneration processes of the kidney | Q34360662 | ||
| Renal microvascular disease determines the responses to revascularization in experimental renovascular disease | Q34548339 | ||
| Epidermal growth factor enhances renal tubule cell regeneration and repair and accelerates the recovery of renal function in postischemic acute renal failure | Q34580512 | ||
| Risk factors in the development of stem cell therapy | Q34761224 | ||
| Ischemic kidney injury and mechanisms of tissue repair | Q34928175 | ||
| Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice | Q35229384 | ||
| Stromal cell-derived factor-1 (SDF1)-dependent recruitment of bone marrow-derived renal endothelium-like cells in a mouse model of acute kidney injury | Q35252477 | ||
| Interleukin-22: immunobiology and pathology | Q35530956 | ||
| Erythropoietin enhances recovery after cisplatin-induced acute renal failure in the rat. | Q43592389 | ||
| Involvement of the activin-follistatin system in tubular regeneration after renal ischemia in rats | Q43680959 | ||
| Counteractive effects of HGF on PDGF-induced mesangial cell proliferation in a rat model of glomerulonephritis | Q44321342 | ||
| Bone morphogenic protein-7 (BMP-7), a novel therapy for diabetic nephropathy | Q44445070 | ||
| BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury | Q44479221 | ||
| Epidermal growth factor accelerates renal tissue repair in a model of gentamicin nephrotoxicity in rats | Q44551119 | ||
| Preconditioning with erythropoietin protects against subsequent ischemia-reperfusion injury in rat kidney | Q44575238 | ||
| Effect of hematopoietic cytokines on renal function in cisplatin-induced ARF in mice | Q45090284 | ||
| Potential role of hepatocyte growth factor in the maintenance of renal structure: anti-apoptotic action of HGF on epithelial cells | Q45889537 | ||
| Prevention of acute kidney injury by erythropoietin in patients undergoing coronary artery bypass grafting: a pilot study. | Q45983756 | ||
| Erythropoietin attenuates renal injury in experimental acute renal failure ischaemic/reperfusion model | Q46749988 | ||
| Heparin-binding epidermal growth factor and Src family kinases in proliferation of renal epithelial cells | Q46825755 | ||
| Osteogenic protein-1 mRNA expression is selectively modulated after acute ischemic renal injury | Q47714308 | ||
| Hematopoietic stem cell mobilization-associated granulocytosis severely worsens acute renal failure | Q47725221 | ||
| Hepatocyte growth factor protects renal epithelial cells from apoptotic cell death | Q47999769 | ||
| Mouse prepro-epidermal growth factor synthesis by the kidney and other tissues | Q48535455 | ||
| Repopulation of porcine kidney scaffold using porcine primary renal cells. | Q51633730 | ||
| Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction. | Q52166842 | ||
| Developmental patterns of PDGF B-chain, PDGF-receptor, and alpha-actin expression in human glomerulogenesis. | Q52230590 | ||
| Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury. | Q54668933 | ||
| Insulin-Like Growth Factor-1 Sustains Stem Cell Mediated Renal Repair | Q57702496 | ||
| Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1 | Q59066124 | ||
| Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action | Q35794379 | ||
| Antagonists of transforming growth factor-beta: a novel approach to treatment of glomerulonephritis and prevention of glomerulosclerosis | Q36058116 | ||
| Structure, Evolution, Expression and Regulation of Insulin-Like Growth Factors I and II | Q36922028 | ||
| VEGF-121 preserves renal microvessel structure and ameliorates secondary renal disease following acute kidney injury | Q37018432 | ||
| Bone morphogenetic protein-7 and connective tissue growth factor: novel targets for treatment of renal fibrosis? | Q37081505 | ||
| The non-haematopoietic biological effects of erythropoietin | Q37103957 | ||
| Insulin-like growth factor I accelerates recovery from ischemic acute tubular necrosis in the rat | Q37342579 | ||
| Chemokine/chemokine receptor-mediated inflammation regulates pathologic changes from acute kidney injury to chronic kidney disease | Q37351560 | ||
| Production of heparin binding epidermal growth factor-like growth factor in the early phase of regeneration after acute renal injury. Isolation and localization of bioactive molecules | Q37366456 | ||
| The Role of Activin A and B and the Benefit of Follistatin Treatment in Renal Ischemia-Reperfusion Injury in Mice | Q37381106 | ||
| Osteogenic protein-1 (bone morphogenetic protein-7) reduces severity of injury after ischemic acute renal failure in rat. | Q37387233 | ||
| Dietary protein restriction rapidly reduces transforming growth factor beta 1 expression in experimental glomerulonephritis | Q37614083 | ||
| Kidney regeneration | Q37728655 | ||
| Toll-like receptor 4-induced IL-22 accelerates kidney regeneration. | Q37733573 | ||
| IL-22 ameliorates renal ischemia-reperfusion injury by targeting proximal tubule epithelium | Q37733579 | ||
| In situ tissue regeneration through host stem cell recruitment | Q38162708 | ||
| Insulin-like growth factors and kidney disease | Q38242675 | ||
| Attenuation of interstitial inflammation and fibrosis by recombinant human erythropoietin in chronic cyclosporine nephropathy. | Q38514934 | ||
| Protective effect of vitamin E against acute kidney injury | Q38592727 | ||
| Epidermal growth factor and the kidney | Q38624084 | ||
| Galectin-3 in Renal Pathology: More Than Just an Innocent Bystander | Q38831547 | ||
| Role of galectin-3 in autoimmune and non-autoimmune nephropathies | Q38964155 | ||
| Comparative Effectiveness of 12 Treatment Strategies for Preventing Contrast-Induced Acute Kidney Injury: A Systematic Review and Bayesian Network Meta-analysis | Q38972985 | ||
| Does Renal Repair Recapitulate Kidney Development? | Q38995182 | ||
| A novel strategy to enhance mesenchymal stem cell migration capacity and promote tissue repair in an injury specific fashion | Q39298233 | ||
| Follistatin, an activin antagonist, ameliorates renal interstitial fibrosis in a rat model of unilateral ureteral obstruction | Q39764178 | ||
| Recombinant human insulin-like growth factor-I accelerates recovery and reduces catabolism in rats with ischemic acute renal failure | Q40304686 | ||
| Multiple roles for platelet-derived growth factor in renal disease | Q40416305 | ||
| Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. | Q40530140 | ||
| Ischemia-reperfusion induces G-CSF gene expression by renal medullary thick ascending limb cells in vivo and in vitro | Q40597519 | ||
| Vascular Endothelial Growth Factor Up-regulation in Human Amniotic Fluid Stem Cell Enhances Nephroprotection After Ischemia-Reperfusion Injury in the Rat. | Q40612446 | ||
| Roles of growth hormone and growth factors in the pathogenesis and treatment of kidney disease | Q40629389 | ||
| BMP7 antagonizes TGF-beta -dependent fibrogenesis in mesangial cells | Q40658343 | ||
| Growth hormone, the insulin-like growth factor system, and the kidney | Q41192750 | ||
| Could Vitamin E Prevent Contrast-Induced Acute Kidney Injury? A Systematic Review and Meta-Analysis. | Q41285597 | ||
| Enhanced protection against renal ischemia-reperfusion injury with combined melatonin and exendin-4 in a rodent model | Q41360782 | ||
| Expressions of receptor gene for hepatocyte growth factor in kidney after unilateral nephrectomy and renal injury | Q41602619 | ||
| Fibrosis, a common pathway to organ failure: angiotensin II and tissue repair | Q41605140 | ||
| Effect of scatter factor and hepatocyte growth factor on motility and morphology of MDCK cells | Q41626187 | ||
| Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor | Q41656206 | ||
| Prospect of stem cell conditioned medium in regenerative medicine. | Q41660528 | ||
| Melatonin protects kidney against apoptosis induced by acute unilateral ureteral obstruction in rats | Q42354259 | ||
| Role of SDF-1 as a regulatory chemokine in renal regeneration after acute kidney injury | Q42727653 | ||
| SDF-1 provides morphological and functional protection against renal ischaemia/reperfusion injury | Q43414442 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | acute kidney injury | Q424337 |
| kidney disease | Q1054718 | ||
| regenerative medicine | Q1061415 | ||
| tissue engineering | Q1540285 | ||
| cell- and tissue-based therapy | Q65593162 | ||
| P304 | page(s) | 1015-1025 | |
| P577 | publication date | 2018-11-01 | |
| P1433 | published in | Yonsei Medical Journal | Q8055114 |
| P1476 | title | Bioactive Compounds for the Treatment of Renal Disease | |
| P478 | volume | 59 |
| Q64096846 | Dietary Components That May Influence the Disturbed Gut Microbiota in Chronic Kidney Disease | cites work | P2860 |
Search more.